{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T14:42:14Z","timestamp":1772635334976,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Radiologic Clinics of North America"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1016\/j.rcl.2004.09.011","type":"journal-article","created":{"date-parts":[[2005,4,18]],"date-time":"2005-04-18T10:53:11Z","timestamp":1113821591000},"page":"23-33","source":"Crossref","is-referenced-by-count":49,"title":["Fluorodeoxyglucose-PET in the management of malignant melanoma"],"prefix":"10.1016","volume":"43","author":[{"given":"Rakesh","family":"Kumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayse","family":"Mavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gonca","family":"Bural","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abass","family":"Alavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rcl.2004.09.011_bib2","doi-asserted-by":"crossref","first-page":"3622","DOI":"10.1200\/JCO.2001.19.16.3622","article-title":"Prognostic factor analysis of 17 600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system","volume":"19","author":"Balch","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.rcl.2004.09.011_bib3","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1046\/j.1365-2133.2002.04867.x","article-title":"Metastatic pathways and time courses in the orderly progression of cutaneous melanoma","volume":"147","author":"Meier","year":"2002","journal-title":"Br J Dermatol"},{"issue":"Suppl 1","key":"10.1016\/j.rcl.2004.09.011_bib4","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1007\/s00259-003-1159-4","article-title":"Computerised tomography in the staging of Hodgkin's disease and non-Hodgkin's lymphoma","volume":"30","author":"Vinnicombe","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"11","key":"10.1016\/j.rcl.2004.09.011_bib5","first-page":"1831","article-title":"The potential of 2-deoxy-2[18F]fluoro-D-glucose (FDG) for the detection of tumor involvement in lymph nodes","volume":"31","author":"Wahl","year":"1990","journal-title":"J Nucl Med"},{"key":"10.1016\/j.rcl.2004.09.011_bib6","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1200\/JCO.1999.17.3.976","article-title":"Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients","volume":"17","author":"Gershenwald","year":"1999","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.rcl.2004.09.011_bib7","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.bjps.2003.03.002","article-title":"Five years of sentinel node biopsy for melanoma: the St George's Melanoma Unit experience","volume":"57","author":"Topping","year":"2004","journal-title":"Br J Plast Surg"},{"issue":"12","key":"10.1016\/j.rcl.2004.09.011_bib8","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1001\/archderm.1995.01690240048008","article-title":"Positron emission tomography and ultrasonography. A comparative retrospective study assessing the diagnostic validity in lymph node metastases of malignant melanoma","volume":"131","author":"Blessing","year":"1995","journal-title":"Arch Dermatol"},{"issue":"3","key":"10.1016\/j.rcl.2004.09.011_bib9","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/(SICI)1096-9098(199703)64:3<181::AID-JSO2>3.0.CO;2-6","article-title":"Initial assessment of positron emission tomography for detection of nonpalpable regional lymphatic metastases in melanoma","volume":"64","author":"Wagner","year":"1997","journal-title":"J Surg Oncol"},{"issue":"5","key":"10.1016\/j.rcl.2004.09.011_bib10","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1200\/JCO.1998.16.5.1770","article-title":"Prospective evaluation of 2-[18F]-2-deoxy-D-glucose positron emission tomography in staging of regional lymph nodes in patients with cutaneous malignant melanoma","volume":"16","author":"Macfarlane","year":"1998","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.rcl.2004.09.011_bib11","first-page":"1491","article-title":"Which kinds of lymph node metastases can FDG PET detect? A clinical study in melanoma","volume":"41","author":"Crippa","year":"2000","journal-title":"J Nucl Med"},{"key":"10.1016\/j.rcl.2004.09.011_bib12","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1200\/JCO.1999.17.5.1508","article-title":"Prospective study of fluorodeoxyglucose-positron emission tomography imaging of lymph node basins in melanoma patients undergoing sentinel node biopsy","volume":"17","author":"Wagner","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.rcl.2004.09.011_bib13","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1200\/JCO.2001.19.10.2674","article-title":"Comparison of positron emission tomography scanning and sentinel node biopsy in the detection of micrometastases of primary cutaneous melanoma","volume":"19","author":"Acland","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.rcl.2004.09.011_bib14","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S0748-7983(03)00147-1","article-title":"Fluorodeoxyglucose-positron emission tomography and sentinel lymph node biopsy in staging primary cutaneous melanoma","volume":"29","author":"Havenga","year":"2003","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"10.1016\/j.rcl.2004.09.011_bib15","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1046\/j.1524-4725.2003.29058.x","article-title":"Fluorodeoxyglucose-positron emission tomography imaging versus sentinel node biopsy in the primary staging of melanoma patients","volume":"29","author":"Longo","year":"2003","journal-title":"Dermatol Surg"},{"issue":"2","key":"10.1016\/j.rcl.2004.09.011_bib16","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/00008390-200404000-00011","article-title":"Positron emission tomography is not useful in detecting metastasis in the sentinel lymph node in patients with primary malignant melanoma stage I and II","volume":"14","author":"Fink","year":"2004","journal-title":"Melanoma Res"},{"issue":"4","key":"10.1016\/j.rcl.2004.09.011_bib17","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/j.0007-0963.2004.05870.x","article-title":"Baseline staging in cutaneous malignant melanoma","volume":"150","author":"Hafner","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.rcl.2004.09.011_bib18","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1055\/s-0038-1632245","article-title":"Contribution of whole body F-18-FDG-PET and lymphoscintigraphy to the assessment of regional and distant metastases in cutaneous malignant melanoma: a pilot study","volume":"39","author":"Klein","year":"2000","journal-title":"Nuklearmedizin"},{"key":"10.1016\/j.rcl.2004.09.011_bib19","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/jso.1102","article-title":"FDG-PET sensitivity for melanoma lymph node metastases is dependent on tumor volume","volume":"77","author":"Wagner","year":"2001","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.rcl.2004.09.011_bib20","first-page":"153","article-title":"A review of the literature for whole-body FDG PET in the management of patients with melanoma","volume":"44","author":"Schwimmer","year":"2000","journal-title":"Q J Nucl Med"},{"issue":"5","key":"10.1016\/j.rcl.2004.09.011_bib21","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1080\/028418500127345668","article-title":"Fluor-18-fluorodeoxyglucose positron emission tomography (FDG-PET) in malignant melanoma. Diagnostic comparison with conventional imaging methods","volume":"41","author":"Krug","year":"2000","journal-title":"Acta Radiol"},{"issue":"9","key":"10.1016\/j.rcl.2004.09.011_bib22","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1002\/(SICI)1097-0142(19980501)82:9<1664::AID-CNCR11>3.0.CO;2-2","article-title":"Primary staging and follow-up of high risk melanoma patients with whole-body 18F-fluorodeoxyglucose positron emission tomography: results of a prospective study of 100 patients","volume":"82","author":"Rinne","year":"1998","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.rcl.2004.09.011_bib23","first-page":"1420","article-title":"Initial assessment of positron emission tomography using 2-fluorine-18-fluoro-2-deoxy-D-glucose in the imaging of malignant melanoma","volume":"34","author":"Gritters","year":"1993","journal-title":"J Nucl Med"},{"issue":"3","key":"10.1016\/j.rcl.2004.09.011_bib24","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1148\/radiology.195.3.7753998","article-title":"Malignant melanoma: staging with whole-body positron emission tomography and 2-[F-18]-fluoro-2-deoxy-D-glucose","volume":"195","author":"Steinert","year":"1995","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.rcl.2004.09.011_bib25","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/00008390-199608000-00008","article-title":"Positron emission tomography in the detection and management of metastatic melanoma","volume":"6","author":"Damian","year":"1996","journal-title":"Melanoma Res"},{"issue":"5","key":"10.1016\/j.rcl.2004.09.011_bib26","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1097\/00000658-199805000-00017","article-title":"Effectiveness of positron emission tomography for the detection of melanoma metastases","volume":"227","author":"Holder","year":"1998","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.rcl.2004.09.011_bib27","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/PL00006666","article-title":"Use of fluorine-18 fluorodeoxyglucose positron emission tomography in the detection of silent metastases from malignant melanoma","volume":"27","author":"Eigtved","year":"2000","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.rcl.2004.09.011_bib28","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/1097-0142(20000901)89:5<1019::AID-CNCR11>3.0.CO;2-0","article-title":"Positron emission tomography scanning in malignant melanoma","volume":"89","author":"Tyler","year":"2000","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.rcl.2004.09.011_bib29","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1067\/mjd.2000.101448","article-title":"The value of positron emission tomography scanning in the detection of subclinical metastatic melanoma","volume":"42","author":"Acland","year":"2000","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"10.1016\/j.rcl.2004.09.011_bib30","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1007\/BF02574480","article-title":"Positron emission tomography is superior to computed tomography for metastatic detection in melanoma patients","volume":"9","author":"Swetter","year":"2002","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"10.1016\/j.rcl.2004.09.011_bib31","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1245\/ASO.2004.01.023","article-title":"A prospective analysis of positron emission tomography and conventional imaging for detection of stage IV metastatic melanoma in patients undergoing metastasectomy","volume":"11","author":"Finkelstein","year":"2004","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.rcl.2004.09.011_bib32","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/00008390-200209000-00010","article-title":"18-FDG PET scan in the staging of recurrent melanoma: additional value and therapeutic impact","volume":"12","author":"Stas","year":"2002","journal-title":"Melanoma Res"},{"issue":"5","key":"10.1016\/j.rcl.2004.09.011_bib33","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/00006231-200205000-00008","article-title":"Reproducibility and clinical value of 18F-fluorodeoxyglucose positron emission tomography in recurrent melanoma","volume":"23","author":"Mijnhout","year":"2002","journal-title":"Nucl Med Commun"},{"issue":"8","key":"10.1016\/j.rcl.2004.09.011_bib34","first-page":"1323","article-title":"Is 18F-FDG PET more accurate than standard diagnostic procedures in the detection of suspected recurrent melanoma?","volume":"45","author":"Fuster","year":"2004","journal-title":"J Nucl Med"},{"issue":"1","key":"10.1016\/j.rcl.2004.09.011_bib35","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/00003072-200001000-00011","article-title":"The effect of fluorine-18 fluorodeoxyglucose positron emission tomography on the management of cutaneous malignant melanoma","volume":"25","author":"Jadvar","year":"2000","journal-title":"Clin Nucl Med"},{"issue":"2","key":"10.1016\/j.rcl.2004.09.011_bib36","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S1536-1632(01)00003-8","article-title":"The impact of 2-deoxy-2[18F] fluoro-D-glucose whole body positron emission tomography for managing patients with melanoma: the referring physician's perspective","volume":"4","author":"Wong","year":"2002","journal-title":"Mol Imaging Biol"},{"issue":"12","key":"10.1016\/j.rcl.2004.09.011_bib37","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1097\/01.rlu.0000099805.36471.aa","article-title":"The role of fluorine-18 deoxyglucose positron emission tomography in the management of patients with metastatic melanoma: impact on surgical decision making","volume":"28","author":"Gulec","year":"2003","journal-title":"Clin Nucl Med"}],"container-title":["Radiologic Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033838904001885?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033838904001885?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,13]],"date-time":"2019-02-13T19:53:59Z","timestamp":1550087639000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033838904001885"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["S0033838904001885"],"URL":"https:\/\/doi.org\/10.1016\/j.rcl.2004.09.011","relation":{},"ISSN":["0033-8389"],"issn-type":[{"value":"0033-8389","type":"print"}],"subject":[],"published":{"date-parts":[[2005,1]]}}}